Ziac is a combination antihypertensive medication that contains the active ingredients hydrochlorothiazide and amiloride. It is prescribed to help patients with high blood pressure by reducing fluid retention through the kidneys. Hydrochlorothiazide works as a diuretic that increases the excretion of sodium and water, lowering blood volume. Amiloride blocks sodium channels in the distal tubules, preventing potassium loss while also contributing to diuresis. Together they modulate the renin-angiotensin-aldosterone system, leading to relaxed vascular resistance and improved cardiac output. The drug's mechanism reduces extracellular fluid volume and systemic vascular resistance, which directly lowers arterial pressure. These actions collectively maintain blood pressure within a healthier range and are characteristic of the medication's pharmacodynamic profile.

Ziac is a prescription medication that combines hydrochlorothiazide with amiloride in a fixed ratio for treating high blood pressure and fluid retention. The formulation provides a thiazide diuretic effect by inhibiting sodium chloride reabsorption in the distal convoluted tubule. At the same time amiloride blocks epithelial sodium channels in the collecting duct which reduces sodium reabsorption and helps preserve potassium levels. Together the two agents increase urinary excretion of water and sodium while maintaining electrolyte balance. This combined action leads to a reduction in plasma volume which lowers arterial pressure and eases the workload of the heart. The medication therefore serves a dual therapeutic role of blood pressure control and management of mild to moderate heart failure symptoms. By modulating renal sodium handling Ziac alters physiological fluid regulation to achieve its intended clinical effect.

Dizziness or lightheadedness may occur, especially after the first dose. Increased urination can lead to fluid loss and mild dehydration. Low potassium levels are possible, which may cause muscle weakness. Some patients experience mild electrolyte imbalances, such as low sodium. Elevated blood sugar has been reported in rare cases. Slight increases in cholesterol levels have been observed in certain individuals. Skin reactions like rash or itching can develop occasionally. Digestive discomfort such as mild nausea or stomach upset may appear.

Ziac may cause dizziness especially when standing up quickly. A persistent dry cough can develop due to the ace inhibitor component of Ziac. Some people experience elevated potassium levels in the blood while taking Ziac. Blood pressure reductions sometimes lead to lightheadedness. Headaches are reported by a portion of users of Ziac. Fatigue or a general feeling of weakness can appear. Changes in kidney function may be observed in certain individuals on Ziac. Gout attacks may be triggered by increased uric acid levels associated with Ziac.